Alcon Laboratories (India) Private Limited

Alcon Laboratories (India) Private Limited - healthcare in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U33119KA1999FTC025496 Incorporated 21 July 1999 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Foreign Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹2,236.52 Cr
▲ 10% YoY
Net profit · FY 2025
₹136.22 Cr
Net margin 6.1%
EBITDA · FY 2025
₹239.72 Cr
EBITDA margin 10.7%
Authorised capital
₹161.75 Cr
Registered with MCA
Paid-up capital
₹160.57 Cr
Issued & subscribed
Company age
27 yrs
Est. 1999
Employees · EPFO
1,757
Provident fund records
Directors on board
2
As per MCA filings

About Alcon Laboratories (India) Private Limited

Data last updated:

Alcon Laboratories (India) Private Limited is a foreign private limited company based in Bengaluru, Karnataka, India, a subsidiary of Alcon Inc. It operates in the eye care and ophthalmology clinics segment of the healthcare sector. It was incorporated on 21 July 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33119KA1999FTC025496. Its GSTIN is 29AACCA3430F1Z2 (Karnataka). The company holds 23 GST registrations, all of them active.

The company has an authorised share capital of ₹161.75 Cr and a paid-up capital of ₹160.57 Cr. It is led by directors Karthick (Whole-Time Director) and Amar Rashmikant Vyas (Whole-Time Director).

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 11th Floor Rmz Azure Bellary Road Hebbal, Bengaluru, Karnataka, India – 560092.

As per the financials filed for FY 2025, the company reported a revenue of ₹2,236.52 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹136.22 Cr (net margin 6.1%) and EBITDA of ₹239.72 Cr (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 16% over five years.

The company has about 1,757 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Alcon. Court records list 88 cases involving the company, including 57 filed by the company and 31 filed against it; 22 cases are pending. The company has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹110 Cr; the latest was in July 2020. The company has 18 MSME Form 1 returns on record between 2019 and 2024, listing 1,469 overdue payments to 75 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alcon.com.

Company details

CIN U33119KA1999FTC025496
Registration Number 025496
Incorporation Date 21 July 1999
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Alcon Inc
Compliance Status Active Compliant

CIN history

Alcon Laboratories (India) has one previous CIN (Corporate Identification Number): U33119KA1999PTC025496. The current CIN is U33119KA1999FTC025496, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33119KA1999FTC025496Current
U33119KA1999PTC025496Previous

Contact details

Alcon Laboratories (India) Private Limited's registered office is in Bengaluru, Karnataka. Its website is alcon.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    11th Floor Rmz Azure Bellary Road Hebbal, Bengaluru, Karnataka, India – 560092
  • Industry
    Healthcare, Eye Care & Ophthalmology Clinics

To see the full contact details of Alcon Laboratories (India) Private Limited, buy the company report.

Comprehensive company report
Alcon Laboratories (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Alcon Laboratories (India) operates one associated brand: Alcon. Each brand links to its own profile.

BrandDescriptionWebsite
Developer of a wide range of eye care productsalcon.com

Business activity

The main business activity of Alcon Laboratories (India) is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Alcon Laboratories (India) Private Limited, buy the company report.

Financials of Alcon Laboratories (India) Private Limited

FY 2025 filings available

Alcon Laboratories (India) Private Limited reported revenue of ₹2,236.52 Cr (up 10% YoY) for FY 2025.

Revenue · FY 2025
₹2,236.52 Cr ▲ 10%
Net profit · FY 2025
₹136.22 Cr margin 6.1%
EBITDA · FY 2025
₹239.72 Cr margin 10.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 24%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 9%
5 years · compounded
▲ 25%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 10% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹239.72 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹136.22 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.7%
Net Profit Margin6.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alcon Laboratories (India) Private Limited, buy the company report.

Board of directors of Alcon Laboratories (India) Private Limited

Alcon Laboratories (India) has 2 current directors and 30 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
KarthickWhole-Time Director23 Oct 20197 Years 0 MonthsCurrent
Amar Rashmikant VyasWhole-Time Director01 Apr 20224 Years 6 MonthsCurrent

Auditor

Alcon Laboratories (India) Private Limited is audited by Haribhakti & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Haribhakti & Co. LLPFY 2023103523W/ W100048

Shareholding

The shareholding of Alcon Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alcon Laboratories (India) Private Limited, buy the company report.

Deals & funding

Alcon Laboratories (India) Private Limited has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹110 Cr; the latest was in July 2020.

Total deals
5
Rights issues
2
Secondary share transfers
2
Funding round
1
Disclosed funding
₹110 Cr

Deals on record (5 of 5)

WhenDealAmountParties
Jul 2020Rights issue₹225.24 CrInvestors: Alcon Inc
Feb 2019Secondary share transferUndisclosedBuyer: Alcon Inc
Seller: Novartis AG
Aug 2018Rights issue₹2.02 CrInvestors: Novartis AG
Mar 2018Secondary share transferUndisclosedBuyer: Novartis AG
Seller: Alcon Inc
Jun 2009Funding round₹110 CrInvestors: Alcon Inc

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Alcon Laboratories (India) Private Limited has 18 MSME Form 1 returns on record between 2019 and 2024, listing 1,469 overdue payments to 75 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 75)

SupplierAmount dueDue sinceReported on
Scarecrow M&C Saatchi Limited
an individual supplier
Digitop Digital Transformation Consulting Services Private Limited
P.M. Relocations Private Limited
an individual supplier

To see the full MSME payment records of Alcon Laboratories (India) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Alcon Laboratories (India) Private Limited has a workforce of 1,757 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
1,757
Active EPFO establishments
1
Employee growth
13.87%

GST

Alcon Laboratories (India) has 23 GST registrations: 23 active. The first 4 active GSTINs are listed below.

Total GSTINs
23
Active
23
GSTINStateStatusRegistered on
29AACCA3430F1Z2KarnatakaActive01 Jul 2017
29AACCA3430F2Z1KarnatakaActive01 Jul 2018
07AACCA3430F1Z8DelhiActive01 Jul 2017
24AACCA3430F1ZCGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Alcon Laboratories (India) Private Limited, buy the company report.

Recent activity

Alcon Laboratories (India) Private Limited has 30 board changes on record since 2007: 3 appointments and 27 cessations. The latest: Amar Rashmikant Vyas ceased to be Additional Director on 29 Nov 2022.

AGM
Alcon Laboratories (India) Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Filing
Alcon Laboratories (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Amar Rashmikant Vyas ceased to be Additional Director.
Appointed
Amar Rashmikant Vyas was appointed as Whole-Time Director.
Ceased
Shalav Pradyuman Modi ceased to be Director.
Ceased
Karthick ceased to be Additional Director.
Ceased
Alexander Leopold Joramsa ceased to be Director.
Ceased
Rajkumar Narayanan ceased to be Director.
Ceased
Sunil Vasanth Dhotre ceased to be Director.
Appointed
Karthick was appointed as Whole-Time Director.
Ceased
Vijayanarayanan ceased to be Director.
Ceased
Sanjeev Shrivastav ceased to be Additional Director.

21 earlier events are in the company report.

Frequently asked questions

Alcon Laboratories (India) is an active foreign private limited company based in Bengaluru, Karnataka, India. The company works in eye care and ophthalmology clinics, within the healthcare industry. It was incorporated on 21 July 1999 (27+ years old) and is registered under CIN U33119KA1999FTC025496.

Alcon Laboratories (India) has 2 current directors:

The latest financial statements of Alcon Laboratories (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Alcon Laboratories (India) is 29AACCA3430F1Z2, registered in Karnataka. The company has 23 GST registrations in all, of which 23 are active. Other active GSTINs include 29AACCA3430F2Z1 (Karnataka), 07AACCA3430F1Z8 (Delhi), 24AACCA3430F1ZC (Gujarat).

The CIN (Corporate Identification Number) of Alcon Laboratories (India) is U33119KA1999FTC025496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alcon Laboratories (India) has 88 court cases on record: 57 filed by the company and 31 filed against it. 22 are pending. Most are in the district courts.

Alcon Laboratories (India) was incorporated on 21 July 1999, making it 27+ years old. It is registered with the Registrar of Companies, Bangalore.

Alcon Laboratories (India) has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹110 Cr; the latest was in July 2020.

Amar Rashmikant Vyas ceased to be Additional Director on 29 Nov 2022. Amar Rashmikant Vyas was appointed as Whole-Time Director on 01 Apr 2022. Shalav Pradyuman Modi ceased to be Director on 01 Apr 2022. Alcon Laboratories (India) has 30 board changes on record in total.

Alcon Laboratories (India) has 18 MSME Form 1 returns on record between 2019 and 2024, listing 1,469 overdue payments to 75 micro and small suppliers. The latest return was filed on 22 Apr 2024.

Alcon Laboratories (India) can be reached through the website alcon.com. Its registered office is in Bengaluru, Karnataka, India.